(2S,4R)-1-((S)-2-(tert-butyl)-14-(4-(((2-fluoro-3-((4-methyl-2-oxo-7-(pyrimidin-2-yloxy)-2H-chromen-3-yl)methyl)phenyl)amino)methyl)-1H-1,2,3-triazol-1-yl)-6,9,12-trioxa-3-azatetradecanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide

ID: ALA5278279

Chembl Id: CHEMBL5278279

Max Phase: Preclinical

Molecular Formula: C55H65FN10O9S

Molecular Weight: 1061.25

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NCCOCCOCCOCCn2cc(CNc3cccc(Cc4c(C)c5ccc(Oc6ncccn6)cc5oc4=O)c3F)nn2)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C55H65FN10O9S/c1-34-43-16-15-42(74-54-58-17-8-18-59-54)29-47(43)75-53(70)44(34)27-39-9-7-10-45(48(39)56)60-30-40-31-65(64-63-40)20-22-72-24-26-73-25-23-71-21-19-57-50(55(4,5)6)52(69)66-32-41(67)28-46(66)51(68)62-35(2)37-11-13-38(14-12-37)49-36(3)61-33-76-49/h7-18,29,31,33,35,41,46,50,57,60,67H,19-28,30,32H2,1-6H3,(H,62,68)/t35-,41+,46-,50+/m0/s1

Standard InChI Key:  NPFIGSYRYNDRCW-ULINFHPISA-N

Alternative Forms

  1. Parent:

    ALA5278279

    ---

Associated Targets(Human)

MAP2K2 Tclin VHL-MAP2K1/MAP2K2 (64 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1061.25Molecular Weight (Monoisotopic): 1060.4641AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Wang C, Wang H, Zheng C, Li B, Liu Z, Zhang L, Yuan L, Xu P..  (2023)  Discovery of Coumarin-Based MEK1/2 PROTAC Effective in Human Cancer Cells.,  14  (1.0): [PMID:36655129] [10.1021/acsmedchemlett.2c00446]

Source